Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like AbbVie Wins FDA Approval for the First-Ever Drug to Treat All Forms of Hep C August 3, 2017 InstantLabs Secures Controlling Investment From February 23, 2017 Bay Area Bigfoot Biomedical Bags $37M Series B Financing December 18, 2017
